Mild to Moderate Parkinson's

Parkinson's disease is a progressive neurodegenerative disorder that affects the nerve cells in the substantia nigra and can cause motor or non-motor related symptoms. Learn More

Phase: II

Time Frame: 14 weeks

Age requirements: 50 to 75 years of age

Compensation available

Key Inclusion Criteria:

  • Male and female subjects between 50 and 75 years of age.
  • Confirmed diagnosis of Parkinson’s disease.

Additional Criteria:
At screening visit, additional criteria will be reviewed to determine eligibility for the study. Qualified participants will receive study medication, medical care and compensation for the time and travel of each completed study visit.

Back to list


Thank you for your interest in our studies. Please use the following form to begin your enrollment process in a clinical trial or to join our database of opted-in patients. You will receive notification via email and/or regular mail about new clinical trial opportunities.

Fields marked with an asterisk (*) are required.

I am interested in the following studies:

By completing this form, you are not committing to participate in a clinical research study or being selected as a study participant. You will be given the option to select whether or not you'd like to be considered for potential participation.